miR-545 inhibited pancreatic ductal adenocarcinoma growth by targeting RIG-I

被引：49

作者：

Song, Bin ^{[1
]}

Ji, Weiping ^{[1
]}

Gu, Shiwei ^{[1
]}

Liu, Anan ^{[1
]}

Jing, Wei ^{[1
]}

Shao, Chenghao ^{[1
]}

Li, Gang ^{[1
]}

Jin, Gang ^{[1
]}

机构：

[1] Second Mil Med Univ, Dept Pancreat Surg, Changhai Hosp, Shanghai 200082, Peoples R China

来源：

FEBS LETTERS | 2014年 / 588卷 / 23期

基金：

上海市自然科学基金;

关键词：

miR-545; Pancreatic ductal adenocarcinoma; RIG-I; Patients survival; Cancer growth; HEPATOCELLULAR-CARCINOMA; MICRORNAS; CANCER; RECOGNITION; SURVIVAL; RNA; ACTIVATION; APOPTOSIS; GENES; CELLS;

D O I：

10.1016/j.febslet.2014.10.004

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Pancreatic ductal adenocarcinoma (PDAC) ranks fourth on the list of cancer-related causes of death. Deregulation or dysfunction of miRNAs contribute to cancer development. In this study, we found that low miR-545 level and high RIG-I protein in PDAC tissues were both correlated with low survival rate. MiR-545 up-regulation inhibited PDAC cell lines growth and vice versa. 3'UTR of RIG-I was targeted by miR-545. Thus we concluded that low miR-545 levels in PDAC promote tumor cells growth, and this is associated with reduced survival in PDAC patients. MiR-545 exerts its effects by directly targeting RIG-1. (C) 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

引用

页码：4375 / 4381

页数：7

共 50 条

[11] miR-26a suppresses the growth and metastasis via targeting matrix metalloproteinase 14 in pancreatic ductal adenocarcinoma
Zhong, Yuchuan
Yao, Guowang
Zhao, Guang
Zhang, Dapeng
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (04): : 4803 - 4809
[12] RNF122 suppresses antiviral type I interferon production by targeting RIG-I CARDs to mediate RIG-I degradation
Wang, Wendie
Jiang, Minghong
Liu, Shuo
Zhang, Shikun
Liu, Wei
Ma, Yuanwu
Zhang, Lianfeng
Zhang, Jiyan
Cao, Xuetao
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (34) : 9581 - 9586
[13] Interplay of miR-21 and FoxO1 modulates growth of pancreatic ductal adenocarcinoma
Song, Weifeng
Wang, Lei
Wang, Liwei
Li, Qi
TUMOR BIOLOGY, 2015, 36 (06) : 4741 - 4745
[14] MiR-202-5p Inhibits RIG-I-Dependent Innate Immune Responses to RGNNV Infection by Targeting TRIM25 to Mediate RIG-I Ubiquitination
Liu, Wei
Jin, Yilin
Zhang, Wanwan
Xiang, Yangxi
Jia, Peng
Yi, Meisheng
Jia, Kuntong
VIRUSES-BASEL, 2020, 12 (03):
[15] MiR-708-5p inhibits the progression of pancreatic ductal adenocarcinoma by targeting Sirt3
Huang, Shanshan
Guo, Hui
Cao, Yuan
Xiong, Jianping
PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (04) : 794 - 800
[16] Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients
Sun, BoLin
Liu, Xiaogang
Gao, Yewu
Li, Li
Dong, ZhenLing
BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2016, 73 (04) : 152 - 157
[17] Expression of epidermal growth factors and apoptosis markers in pancreatic ductal adenocarcinoma
Pryczynicz, Anna
Guzinska-Ustymowicz, Katarzyna
Czyzewska, Jolanta
Kemona, Andrzej
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2009, 47 (04) : 667 - 671
[18] Modulation of FoxO1 Expression by miR-21 to Promote Growth of Pancreatic Ductal Adenocarcinoma
Song, Weifeng
Li, Qi
Wang, Lei
Wang, Liwei
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 35 (01) : 184 - 190
[19] The role of miR-10b in metastatic pancreatic ductal adenocarcinoma
Frampton, Adam E.
Krell, Jonathan
Zhang, Yaojun
Stebbing, Justin
Castellano, Leandro
Jiao, Long R.
SURGERY, 2012, 152 (05) : 936 - 938
[20] Epstein-Barr Virus miR-BART6-3p Inhibits the RIG-I Pathway
Lu, Yuanjun
Qin, Zailong
Wang, Jia
Zheng, Xiang
Lu, Jianhong
Zhang, Xuemei
Wei, Lingyu
Peng, Qiu
Zheng, Ying
Ou, Chunlin
Ye, Qiurong
Xiong, Wei
Li, Guiyuan
Fu, Yuxin
Yan, Qun
Ma, Jian
JOURNAL OF INNATE IMMUNITY, 2017, 9 (06) : 574 - 586

← 1 2 3 4 5 →